Partners John Eliason and Mike Crossen were quoted in an American Banker article, “Banks explore ways to capitalize on tax law’s ‘Opportunity Zones,’” about potential business opportunities created by Opportunity Zones, an element of the federal tax cut law enacted in December 2017 that provides a way for private investors to receive tax benefits in exchange for investing in low- and moderate-income communities.
Eliason, who advises banks and private investors on tax issues, said such zones are fertile ground for private investment. “There is an estimated $6 trillion in investment opportunities that could be unlocked from this program,” he said.
Crossen, who has a public policy and transaction practice, said he takes the view that commercial and industrial loans will be eligible for the Opportunity Zones tax benefit. “If it ends up being only real estate, it will be a lost opportunity,” he said.
Eliason, who advises banks and private investors on tax issues, said such zones are fertile ground for private investment. “There is an estimated $6 trillion in investment opportunities that could be unlocked from this program,” he said.
Crossen, who has a public policy and transaction practice, said he takes the view that commercial and industrial loans will be eligible for the Opportunity Zones tax benefit. “If it ends up being only real estate, it will be a lost opportunity,” he said.
Related News
26 September 2024
In the News
Gregory Marino on NIL Litigation – 'Schools want to know where the line is, and now everything is in flux'
Foley & Lardner LLP special counsel Gregory Marino shared insight on the growing complexities of collegiate sports in the ABA Journal article, "Money and litigation tangle with recent rules for college athletes' NIL deals."
24 September 2024
In the News
Thomas Ferrante Assesses Recent HHS OIG Report on Remote Patient Monitoring
Foley & Lardner LLP partner Thomas Ferrante commented on the recently released report on remote patient monitoring from the U.S. Department of Health and Human Services Office of Inspector General (OIG) in the Fierce Healthcare article, “HHS watchdog flags potential remote monitoring fraud. Stakeholders say concerns about misuse are overblown.”
20 September 2024
In the News
David Rosen Featured for Insight on Looming FDA Final Rule for Cosmetic Manufacturing
Foley & Lardner LLP partner David Rosen is featured by CosmeticsDesign for his insights on the U.S. Food and Drug Administration's final rule establishing Good Manufacturing Practices for the cosmetics industry in the article, "Preparing for MoCRA’s 2025 cGMP deadline: What cosmetic manufacturers and suppliers need to know."